FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Loratadine-D Extended-Release Tablets Recall

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Nov 3, 2021
Recall ID
D-0068-2022
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Loratadine-D Extended-Release Tablets starting Oct 12, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0068-2022 on Nov 3, 2021. Reason: Failed Moisture Limits. Status: Terminated.

Why it was recalled

Failed Moisture Limits

Product description

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15

Lot numbers, UPCs & expiration codes

Lot #: AC14635, Exp. Date 12/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0068-2022
Classification
Class III
Status
Terminated
Recall initiated
Oct 12, 2021
FDA report date
Nov 3, 2021
Quantity
22,752 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0068-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
88806
Address
2 Independence Way
Code information
Lot #: AC14635, Exp. Date 12/2022
Postal code
08540-6620
Report date
Nov 3, 2021
Product type
Drugs
Recall number
D-0068-2022
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
22,752 blister packs
Termination date
Aug 31, 2023
Reason for recall
Failed Moisture Limits
Voluntary / mandated
Voluntary: Firm initiated
Product description
Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 12, 2021
Initial firm notification
Letter
Center classification date
Oct 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0068-2022, published Nov 3, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls